MetLife Investment Advisors »

Axsome Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 19k 79.59
2023-09-30 $1.3M 19k 69.89
2023-06-30 $1.2M 17k 71.86
2023-03-31 $1.0M 17k 61.68
2022-12-31 $1.3M 17k 77.13
2022-09-30 $729k 16k 44.62
2022-06-30 $664k 17k 38.30
2022-03-31 $718k 17k 41.39
2021-12-31 $412k 11k 37.77
2021-09-30 $360k 11k 33.00
2021-06-30 $736k 11k 67.47
2021-03-31 $618k 11k 56.62
2020-12-31 $889k 11k 81.47
2020-09-30 $877k 12k 71.23
2020-06-30 $1.0M 12k 82.28
2020-03-31 $684k 12k 58.80
2019-12-31 $1.1M 11k 103.37
2019-09-30 $237k 12k 20.26
2019-06-30 $301k 12k 25.75